Press release

NET SALES AS OF JUNE 30, 2018

Longjumeau, Tuesday, July 24, 2018

PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of June 30, 2018.

The PCAS Group had generated consolidated net sales of €100.4 million as of June 30, 2018, representing a decrease of 8.9% compared to the same period of the previous financial year (-7.0% at a constant exchange rate).

eI nmmililliloionsnsofde'ueruorsos

NCehtifsfareleds 'asffoafirJeusnaeu3300 juin

PShyanrtmhèasceuPthicarlmSayncethuetsiqisue FCinheimSpie cFiianletydCehSepméiccialistés

100,4 61,6 38,7

20188

At a constant exchange

A taux de change rate constant

110,2 75,8 34,4

-8,9% -18,6% 12,4%

102,5 -7,0%

63,0 -16,9%

39,6 14,9%

Pharmaceutical Synthesis

The Pharmaceutical Synthesis business generated €61.6 million, down 18.6% compared to 2017 (-16.9% at constant exchange rates), partly due to first half-year multi-stage productions and projects being put back, the sales of which should be achieved over the second part of the year.

Fine Specialty Chemicals

Net sales of Fine Specialty Chemicals totaled €38.7 million, up 12.4% on 2017 (+14.9% at constant exchange rates), with growth in both Performance Additives (Lubricants) and Advanced Specialty Chemicals for the micro-electronics part.

Outlook

In 2018, the Group's net sales are expected to show modest growth. However, the Group income may be noticeably affected if the current euro/USD exchange rate were to worsen.

NEXT FINANCIAL DISCLOSURE:

First half 2018 results, Wednesday, September 05, 2018

ABOUT PCAS

PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With 7% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €218.3 million in 2017 and employs close to 1 100 people in six countries.

To find out more about PCAS, visit:www.pcas.com

PCAS

NewCap

Vincent Touraille / Eric Moissenot

PCAS

Tel. : +33 1 69 79 61 32www.pcas.com

Emmanuel Huynh / Louis-Victor Delouvrier

NewCap

Financial communication and Investor RelationsTel. : +33 1 44 71 98 53pcas@newcap.eu

Attachments

Disclaimer

PCAS SA published this content on 24 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 24 July 2018 16:02:06 UTC